1. Home
  2. GRFS vs VMI Comparison

GRFS vs VMI Comparison

Compare GRFS & VMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • VMI
  • Stock Information
  • Founded
  • GRFS 1940
  • VMI 1946
  • Country
  • GRFS Spain
  • VMI United States
  • Employees
  • GRFS N/A
  • VMI N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • VMI Metal Fabrications
  • Sector
  • GRFS Health Care
  • VMI Industrials
  • Exchange
  • GRFS Nasdaq
  • VMI Nasdaq
  • Market Cap
  • GRFS 6.2B
  • VMI 6.5B
  • IPO Year
  • GRFS 2006
  • VMI N/A
  • Fundamental
  • Price
  • GRFS $10.10
  • VMI $361.19
  • Analyst Decision
  • GRFS Hold
  • VMI Buy
  • Analyst Count
  • GRFS 1
  • VMI 3
  • Target Price
  • GRFS $10.30
  • VMI $391.00
  • AVG Volume (30 Days)
  • GRFS 1.1M
  • VMI 205.1K
  • Earning Date
  • GRFS 01-01-0001
  • VMI 07-22-2025
  • Dividend Yield
  • GRFS N/A
  • VMI 0.75%
  • EPS Growth
  • GRFS N/A
  • VMI 33.33
  • EPS
  • GRFS 0.31
  • VMI 10.81
  • Revenue
  • GRFS $7,968,532,207.00
  • VMI $4,077,331,000.00
  • Revenue This Year
  • GRFS $7.14
  • VMI $1.10
  • Revenue Next Year
  • GRFS $7.16
  • VMI $4.93
  • P/E Ratio
  • GRFS $41.40
  • VMI $33.45
  • Revenue Growth
  • GRFS 10.76
  • VMI N/A
  • 52 Week Low
  • GRFS $6.19
  • VMI $250.07
  • 52 Week High
  • GRFS $10.30
  • VMI $379.22
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 67.23
  • VMI 70.84
  • Support Level
  • GRFS $9.66
  • VMI $352.60
  • Resistance Level
  • GRFS $10.30
  • VMI $363.03
  • Average True Range (ATR)
  • GRFS 0.26
  • VMI 7.44
  • MACD
  • GRFS 0.00
  • VMI 2.21
  • Stochastic Oscillator
  • GRFS 85.19
  • VMI 94.99

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About VMI Valmont Industries Inc.

Valmont Industries Inc, along with its subsidiaries, operates as a manufacturer of products and services for infrastructure and agriculture markets. Its reportable segments are Infrastructure and Agriculture. The company generates maximum revenue from the Infrastructure segment, which includes the manufacturing and distribution of products and solutions to serve the infrastructure markets of utility, solar, lighting and transportation, and telecommunications, along with coatings services to protect metal products. The Agriculture segment provides irrigation equipment components, including aftermarket parts and tubular products, and technology solutions for precision agriculture. Geographically, it derives key revenue from the United States, followed by Australia, Brazil, and other regions.

Share on Social Networks: